Genomics Market Research Report: By Solution (Consumables, Instruments, Services), Technology (PCR, Sequencing, Microarray), Application (Diagnostics, Drug Discovery and Development, Precision Medicine, Agriculture and Animal Research), End User (Research Centers and Academic Institutes, Hospitals and Clinics, Pharmaceutical and Biotechnology Companies) - Global Industry Analysis and Growth Forecast to 2030

Market Outlook

The genomics market value was $18.2 billion in 2019, and the market is predicted to advance at a CAGR of 12.7% between 2020 and 2030. The increasing implementation of favorable government initiatives, falling costs of sequencing services, and mushrooming requirement for personalized medicine are the major factors driving the progress of the market.

The COVID-19 pandemic has forced several government organizations and industry players to conduct research and development (R&D) activities in the domain of genomics. Several organizations are tracking the spread of the infection and initiating research projects for analyzing infected patients, thereby driving the expansion of the market across the world.

Consumables Category Holds Largest Market Revenue Share

The consumables category had the largest share of the market revenue in 2019, under the solution segment. This was primarily due to the huge requirement for consumables on account of the fact that a large number of studies are being carried out at research centers and labs all over the world, wherein numerous samples have to be processed.

Sequencing Set To Exhibit Fastest Growth in Coming Years

The sequencing technology category is predicted to demonstrate the fastest growth in the genomics market in the forthcoming years. This is credited to the surging requirement for this technology and its rapidly falling cost across the globe. As per the National Human Genome Research Institute (NHGRI), the total genome sequencing cost fell from around $10,000 in mid-2011 to approximately $1,000 in 2018.

Diagnostics Category Dominating Industry

The diagnostics application category contributed the highest revenue to the market for genomics solutions in 2019. This is ascribed to the extensive research that is being carried out on various genetic disorders around the world. Furthermore, the adoption of next-generation sequencing (NGS) in diagnostic centers and hospitals helps medical practitioners conduct better disease detection and management, which, in turn, leads to better healthcare.

Research Centers and Academic Institutes Are Biggest End Users

Research centers and academic institutes held the largest share in the market revenue generated from 2014 to 2019, under the end user segment. This is attributed to the fact that a large number of genomics-based projects were conducted at private and public research centers, academic institutes, and universities in the past years.

North America Is Highest-Revenue-Generating Regional Market

North America was the largest genomics market during the last few years because of the existence of several established industry players in the U.S. Furthermore, the huge investments being made in this field by both public and private organizations, including in research projects, are fueling the expansion of the market. The U.S. is witnessing huge investments in this field because of the initiatives launched by the NHGRI. These programs aim to identify the various barriers limiting the adoption of genomics in clinical care and formulate the best practices and solutions for attaining their widespread incorporation in the country.

Asia-Pacific (APAC) Expected To Be Fastest-Growing Region

The surging number of research activities being carried out in the domain of genomics in India, Japan, and China and the soaring investments being made by public and private organizations for this purpose are the main factors propelling the advance of the market for genomics solutions in the APAC region. Currently, China is contributing heavily to the regional market, as the Chinese government had announced the launch of the precision medicine initiative (PMI) in 2016. Developed with an investment of nearly $9 billion, it aims to boost genomics research in the country over the next 15 years. Furthermore, Australia and India are predicted to make huge revenue contributions to the regional market, through investments and research projects, in the forthcoming years.

Collaborations and Partnerships Are Major Trends

One of the most-prominent genomics market trends is collaborations and partnerships among market players. With the help of these collaborations, companies are improving their product portfolio, promoting technological advancements, and expanding their operations in new locations. For example, an agreement was signed between NuProbe Inc., which is a molecular diagnostics company, and Oxford Nanopore Technologies Ltd. in February 2020. This agreement permits NuProbe Inc. to use Oxford Nanopore’s sequencing technology in various clinical applications, such as cancer.

Increasing Implementation of Supportive Government Measures

The implementation of favorable government policies and initiatives, such as the provision of funds for genomics research, is fueling the expansion of the genomics industry across the world. For example, the Indian government announced in 2019 that the Department of Biotechnology (DBT) would soon launch its first-ever human genome mapping project. This project will help researchers and scientists get closer to devising effective treatments for various critical diseases, such as cancer. The project will involve the scanning of as many as 20,000 Indian genomes over a period of five years, for the development of effective therapies and diagnostic tests.

Falling Costs of Sequencing Services

Another major factor fueling the surge in the genomics market revenue is the rapidly declining cost of sequencing services. As a result, the services and deoxyribonucleic acid (DNA) test kits are becoming more affordable for people. This is fueling the development of novel treatment procedures, which is, in turn, leading to improvements in disease diagnosis and management processes.

Soaring Popularity of Personalized Medicine

The burgeoning requirement for personalized medicine is also driving the progress of the market. Different people react differently to a particular treatment and disease, and this is the primary reason behind the ballooning popularity of personalized medicine. Many pharma and biotech firms and institutions around the world are initiating research projects in order to develop precision medicine, for catering to the specific treatment requirements of patients.

Products and Services Being Launched to Gain Competitive Edge in Industry

The global genomics market is consolidated in nature, with the presence of several key players, such as Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., Agilent Technologies Inc., Quest Diagnostics Inc., and Danaher Corporation.

In recent years, players in the genomics industry have launched several solutions to address the different needs of medical centers and patients. For instance:

• In February 2020, BGI Tech Solutions Co. Ltd. announced the commercial availability of its sequencing instruments and reagent kits in the U.S., starting in April 2020; the solutions are based on its CoolMPS sequencing chemistry.
• In November 2019, Thermo Fisher Scientific Inc. announced the launch of Ion Torrent Genexus System, a fully integrated NGS platform, featuring an automated specimen-to-report workflow that delivers results economically, in a single day.

Some of the key players in the genomics market include:

Genomics Market Size Breakdown by Segment

The genomics market report offers comprehensive market segmentation analysis along with market estimation for the period 2014–2030.

Based on Solution

• Consumables
• Instruments
• Services

Based on Technology

• PCR
• Sequencing
• Microarray

Based on Application

• Diagnostics
• Drug discovery and development
• Precision medicine
• Agriculture and animal research

Based on End User

• Research centers and academic institutes
• Hospitals and clinics
• Pharmaceutical and biotechnology companies

Geographical Analysis

• North America
  • U.S.
  • Canada
• Asia-Pacific (APAC)
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Singapore
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Norway
• Latin America (LATAM)
  • Brazil
  • Mexico
• Middle East and Africa (MEA)
  • Saudi Arabia
  • South Africa